Singapore-Based Metabolomics
Early Access Launch of the Orbitrap Exploris™ 120 with 50% Off
Experience comprehensive and highly accurate metabolite identification, delivering robust, publication-ready metabolomics data right here in Singapore. Our newly renovated local laboratory is now accepting samples for the Orbitrap Exploris™ 120 (OE120) platform. To celebrate the launch, enjoy an exclusive 50% discount off all untargeted metabolomics samples — valid until 15 April 2026.
Untargeted Metabolomics Plus vs Pro
Choose from Plus or Pro, both backed by our Singapore-based service and quality guarantee.
Services Untargeted Metabolomics Plus Untargeted Metabolomics Pro
Primary Use Broad screening and hypothesis generation Definitive identification and mechanistic insight
Objective Standard Discovery High-confidence identification, Extensive metabolite coverage
Column C18 C18+HILIC
Database 18k+ Reference Standards, 170k+ Substances 18k+ Reference Standards, 170k+ Substances
Number of Level 1 Identifications Average 900+ Average 1200+
Number of Total Identifications Average 4000+ Average 5000+
Unlock Real-Time Sensitivity with Metabolomics
Changes in the genome or transcriptome can take time to manifest, whereas metabolomics is closer to phenotype, and directly reflects real-time biological responses. This makes it a more sensitive “bridge” for studying acute effects, such as immediate drug response.
Precision You can Publish
Our new Singapore-based lab operates under Novogene’s global quality standards, ensuring rigorous QC implemented during the instrument run. Now, you can access this top-tier quality with an unprecedented 50% early access discount — a rare opportunity to elevate your research cost-effectively.

Act Now: Secure 50% Off + Local Support
Our local team will follow up to discuss your project and quality requirements

Sample Details

Terms and Conditions
• This promotion is valid from 25 March 2026 to 15 April 2026.
• This promotion is available exclusively for clients based in Singapore, and the wider Southeast Asia only.
• A minimum of 12 samples per batch is required. Samples must be received in the Singapore lab by 30 June 2026. 
• The details of this promotion may be subject to changes. NovogeneAIT Genomics reserves the right to interpret and modify these terms as necessary.
 
 
 
About Novogene
Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.
 
For more information, visit novogene.com/amea-en
in   N   X   X   f
© 2026 Novogene Co., Ltd. All Rights Reserved.
For Research Use Only. Not for Clinical Diagnostic Use.
Regional Office for Asia Pacific, Middle-East & Africa:
NovogeneAIT Genomics Pte. Ltd.
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
 
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
 
Novogene Korea
Newv Cloud Hills, BT-230, 231
81 Magokjungang 8-ro 1-gil
Gangseo-gu, Seoul 07790
Republic of Korea